Skip Navigation
Skip to contents

KMJ : Kosin Medical Journal

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Yang Soo Kim 16 Articles
Retrospective analysis on the clinical efficacy of bevacizumab combined with FOLFOX4 in the first line treatment of metastatic colorectal cancer
Eun Mi Lee, Lee Chun Park, Ho Sup Lee, Seong Hoon Shin, Yang Soo Kim
Kosin Med J. 2017;32(2):170-178.   Published online January 19, 2017
DOI: https://doi.org/10.7180/kmj.2017.32.2.170
  • 316 View
  • 2 Download
Abstract PDFPubReader   ePub   CrossRef-TDMCrossref - TDM
Objectives

The addition of bevacizumab to standard chemotherapy has been improved survival outcomes in patients with metastatic colorectal cancer. However, the combination of bevacizumab with oxaliplatin-based chemotherapy as first-line treatment showed limited survival benefit. The purpose of this study was to investigate the clinical efficacy and toxicity of the combination of bevacizumab to oxaliplatin and leucovorin (FOLFOX4) in the first-line treatment of patient with metastatic colorectal cancer.

Methods

Between December 2004 and September 2009, medical records of patients who were diagnosed with metastatic colorectal cancer and received the first line chemotherapy with bevacizumab and FOLFOX4, were retrospectively reviewed.

Results

A total of forty patients were analyzed. The median age of the patients was 55 years (range, 33-80), and 55% was male. The patients received a total of 206 cycles of therapy (median 4 cycles per patient; range 1 – 15 cycles). Of these 40 patients, none achieved complete response (CR) and 15 achieved a partial response (PR), for the overall response rate (ORR) 37.5% (95% CI, 22.5-52.5). Median progression free survival (PFS) was 6.9 months (95% CI, 3.4-10.5) and median overall survival (OS) was 22.6 months (95% CI, 17.3-27.8The most common grade 3 or 4 hematologic toxicity and non-hematologic toxicity were neutropenia (10.0%) and diarrhea (10.0%), respectively. Two patients experienced gastrointestinal perforation.

Conclusions

In this study, the combination bevacizumab with FOLFOX4 was associated with favorable OS, but did not showed favorable PFS and ORR.

Prognostic Significance of Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Lee Chun Park, Ho Sup Lee, Eun Mi Lee, Seong Hoon Shin, Yang Soo Kim
Kosin Med J. 2016;31(2):122-133.   Published online January 20, 2016
DOI: https://doi.org/10.7180/kmj.2016.31.2.122
  • 364 View
  • 1 Download
  • 1 Citations
Abstract PDFPubReader   ePub   CrossRef-TDMCrossref - TDM
Abstract Objectives

The both values of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) were reported as indexes of systemic inflammation and readily available and inexpensive prognostic markers in patients with solid cancer. The objective of this study was to clarify whether the NLR and PLR were significant prognostic markers in Korean diffuse large B-cell lymphoma (DLBCL) patients treated with R-CHOP as a first line therapy.

Methods

: We retrospectively collected the clinical data of ninety nine DLBCL patients treated with R-CHOP from 2004 to 2012 and analyzed. NLR and PLR were calculated from complete blood count (CBC) and differential leukocyte count.

Results

: In univariate analysis, NLR was significantly associated with 5-year progression free survival(PFS) rate (P= 0.039), but not significantly associated with 5-year overal survival (OS) rate (P= 0.276). PLR was not significantly associated with 5-year PFS (P= 0.632) and OS rate (P= 0.855). In multivariate analysis, NLR was not a significant independent prognostic factor for 5-year PFS (P= 0.415) and OS rate (P= 0.991).

Conclusion

: The NLR can be considered a useful predictor of survival outcome. The PLR is not a valid predictor of survival outcome.

Citations

Citations to this article as recorded by  
  • Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis
    Shidai Mu, Lisha Ai, Fengjuan Fan, You Qin, Chunyan Sun, Yu Hu
    Cancer Cell International.2018;[Epub]     CrossRef
Herpesviridae Viral Infections Following Stem Cell Transplantation in Hematologic Malignancy
Ho Sup Lee, Hee Sang Tag, Seong Hoon Shin, Yang Soo Kim, Sung Jin Nam, Hye Soo Kim, Jin Hee Park, Su Hyeon Jeong, Sung Bin Kim, Ye Na Kim
Kosin Med J. 2010;25(1):20-26.   Published online June 30, 2010
  • 101 View
  • 0 Download
PDF
Cytotoxic Effect of Ganoderma Lucidum to Peripheral Blood Cells
Yang Soo Kim
Kosin Med J. 2008;23(4):20-26.   Published online December 31, 2008
  • 88 View
  • 0 Download
PDF
Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy in Patients with Rectal Cancer of Stage 2 and 3
Ho Sup Lee, Yang Soo Kim
Kosin Med J. 2008;23(4):162-169.   Published online December 31, 2008
  • 81 View
  • 0 Download
PDF
Improved Therapeutic Outcomes of Diffuse Large B cell Lymphoma after Introduction of Rituximab in a Single Institution
Ja Kyung Kim, Yang Soo Kim
Kosin Med J. 2008;23(4):170-175.   Published online December 31, 2008
  • 96 View
  • 0 Download
PDF
A Case of Triple Primary Cancer of Hepatocellular Carcinoma Associated with Esophagogastric Junctional Cancer and Hypopharyngeal Cancer
Yang Soo Kim
Kosin Med J. 2008;23(4):188-192.   Published online December 31, 2008
  • 62 View
  • 0 Download
PDF
A Case of Pneumocystis Carinii Pneumonia in a Patient Receiving Chemotherapy for Rectal Cancer
Yang Soo Kim
Kosin Med J. 2008;23(4):193-196.   Published online December 31, 2008
  • 70 View
  • 0 Download
PDF
4 Cases of Extramedullary Plasmacytomas Treated with Bortezomib and Dexamethasone
Jong Hyun Paek, Eun Young Lee, Ri Ra Jang, Chang Bae Sohn, Eun Kyung Shin, Jeong Ah Seo, Jee Suk Lee, Ho Seop Lee, Sang Min Lee, Seong Hoon Shin, Yang Soo Kim
Kosin Med J. 2007;22(2):216-220.   Published online December 31, 2007
  • 62 View
  • 0 Download
PDF
Apoptosis by Cyanate in Kidney Mesangial Cell
Ji Yeol Kim, Yang Soo Kim, Ki Yeon Hong, Wan Kyu Eo, Young Sik Choi
Kosin Med J. 2007;22(1):160-169.   Published online June 30, 2007
  • 83 View
  • 0 Download
PDF
The Relationship Between Initial Biochemical Bone Markers and Change of Bone Mineral Density in Post Menopausal Women with Hormone Therapy
Chi Heui Cho, Eun Hee Kong, Young Sik Choi, Yang Soo Kim, Heung Yeol Kim, Wan Kyu Eo, Ki Yeon Hong
Kosin Med J. 2007;22(1):212-219.   Published online June 30, 2007
  • 68 View
  • 0 Download
PDF
The Effect of Apoptosis Related Protein Expression by Cyclosporine in Osteoblast
Young Lim Oh, Wan Kyu Eo, Ki Yeon Hong, Yang Soo Kim, Heung Yeol Kim
Kosin Med J. 2007;22(1):232-239.   Published online June 30, 2007
  • 84 View
  • 0 Download
PDF
Change of NK cell activity in case of iron deficiency anemia adult patients
Su Hong Kim, Jeoung Hoon Seo, Yang Soo Kim, Wan Gyu Eo
Kosin Med J. 2005;20(1):49-56.
  • 80 View
  • 1 Download
PDF
A Case of Primary Plasma Cell Leukemia with Atypical Morphology
Byoung Joo Choi, Su Hong Seo, Seong Hoon Chang, Yang Soo Kim, Wan Kyu Eo, Hyo Kyoung Kim
Kosin Med J. 2002;17(1):161-165.
  • 66 View
  • 0 Download
PDF
A case of POEMS syndrome
Soo Hong Seo, Byoung Joo Choi, Chee Whan No, Chae Hee Shin, Seong Hoon Chang, Yang Soo Kim, Wan Kyu Eo, Hyo Kyoung Kim
Kosin Med J. 2002;17(1):152-156.
  • 73 View
  • 0 Download
PDF

KMJ : Kosin Medical Journal